NEURO

Brand Owner (click to sort) Address Description
BONDI NEURO Omniscient Neurotechnology Pty Limited Level 4, 131 Macquarie St. Sydney New South Wales 2000 Australia NEURO;Design and development of medical technologies, namely, imaging apparatuses and equipment for scientific and medical research; Design and development of software in the framework of medical technology; Design and development of medical imaging and diagnostic apparatus; Provision of information in connection with medical and scientific research in the field of neuroscience, neurotechnology, and connectomics; Computer programming in the medical field; Medical research; Biological and medical research services; Scientific research; Scientific research for medical purposes; Scientific research services in the field of medical imaging and diagnostics; Scientific and technological services in the field of medical imaging and diagnostics; Design and writing of computer software, namely, computer program for medical applications; Technical research in the field of neuroscience, cognitive science, machine learning, neurotechnologies and connectomics; Design of computers for others; Design and development of computer hardware and software for use in neurotechnologies and brain computer interfaces; Software design; Software development; Research and development of new products for others; Conducting scientific feasibility studies in the field of neurotechnologies and brain computer interfaces; Software development and design; Software installation; Software maintenance; Updating of software; Rental of computer software; Computer programming; Computer system analysis; Computer system design; Services provided by consultants relating to computer hardware design and development; Cloud computing, namely, cloud hosting provider services for brain imaging data; styling being industrial design; Software as a service (SAAS) services featuring software for neuroscience, neurotechnology, and connectomics research for use in the fields of medical and healthcare; Software as a service (SAAS) services featuring software for medical imaging and diagnostics for use in the fields of medical and healthcare; Software as a service (SAAS) services featuring software for diagnosis, treatment, treatment efficacy evaluation, and patient follow-up; Software as a service (SAAS) services featuring software using artificial intelligence and machine learning algorithms to analyze medical images; Software as a service (SAAS) services featuring software for use in analyzing, accessing, monitoring, and sharing medical images;
DART NEURO Dart NeuroScience 12278 Scripps Summit Dr. San Diego CA 92131 NEURO;Scientific research and technological research in the fields of the development of gene discovery, gene network informatics, drug discovery, and chemistry to identify small molecules and pharmaceuticals for use in treating various brain disorders and for maintaining and enhancing normal brain function; Scientific research and development, namely, development of scientific methods to diagnose functional deficits, including motor and cognitive deficits, in various brain domains, and to rehabilitate those domains with effective brain exercises and training protocols in combination with drugs and pharmaceuticals; Scientific research and development, namely, development of scientific methods to enhance brain function, including motor and cognitive functions, in specific brain domains by combining effective brain exercises and training protocols with drugs and pharmaceuticals; Scientific research and development, namely, development of new scientific computational technologies to predict positive and negative regulators of gene network function; Scientific research and development, namely, development of new scientific algorithms and chemistries to explore chemical space; and development of new technology for others in the field of identifying small molecules that interact with human proteins, particularly in the brain;
NEURO ONE Neurogenix Corp. New York NY 10032 NEURO 1;Processes and services relating to the detection of the generation of new neurons, including a screening platform, method of testing, and analysis;
NEURO360 MyMedMatch, Inc. 235 Cumberland Bend, Suite 118 Nashville TN 37228 NEURO 360; NEURO THREE HUNDRED SIXTY; NEURO THREE SIX ZERO;Health assessment services; Health screening services in the field of neurological conditions; Medical screening services in the field of neurological conditions;
NEURO42 Neuro42, Inc. 70 Washington St., Suite 407 Oakland CA 94607 NEURO 42 ; NEURO FORTY TWO ; NEURO FOUR TWO;Clinical medical imaging services for interoperative procedures; guidance support services in the nature of consultation services in the field of interoperative surgical procedures;Modular MRI system comprised of medical imaging apparatus and medical image processors for medical purposes; magnetic resonance-compatible robotics system comprised of automated medical imaging apparatus for medical purposes; artificial intelligence (AI) based computer-aided platform in the nature of medical imaging apparatus and medical image processors both with embedded artificial intelligence software for diagnosis and tissue characterization for medical purposes;Design, engineering, research, development, laboratory analysis, testing services in the field of MRI systems and MRI-based technologies for medical, scientific, and technological applications;
SPARK NEURO Spark Neuro, Inc. 212 West 18th St. Unit 17A New York NY 10011 NEURO;Technology software, namely, providing temporary use of non-downloadable computer software for allowing researchers to collect patient data in the field of neurology for research relating to early diagnosis of neurological disorders and diseases;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. The invention relates to compounds having a binding affinity for both the ?v?3 receptor and a (neuro)peptide receptor, in particular the somatostatin receptor, which compound comprises a first peptide part comprising at least once the amino acid sequence Arg-Gly-Asp, and a second peptide part coupled thereto, optionally via a linker, which second peptide part is a (neuro)peptide.